1. Home
  2. QNCX vs VTGN Comparison

QNCX vs VTGN Comparison

Compare QNCX & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • VTGN
  • Stock Information
  • Founded
  • QNCX 2012
  • VTGN 1998
  • Country
  • QNCX United States
  • VTGN United States
  • Employees
  • QNCX N/A
  • VTGN N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • VTGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • QNCX Health Care
  • VTGN Health Care
  • Exchange
  • QNCX Nasdaq
  • VTGN Nasdaq
  • Market Cap
  • QNCX 62.0M
  • VTGN 82.7M
  • IPO Year
  • QNCX 2019
  • VTGN N/A
  • Fundamental
  • Price
  • QNCX $1.40
  • VTGN $2.97
  • Analyst Decision
  • QNCX Strong Buy
  • VTGN
  • Analyst Count
  • QNCX 4
  • VTGN 0
  • Target Price
  • QNCX $9.50
  • VTGN N/A
  • AVG Volume (30 Days)
  • QNCX 126.6K
  • VTGN 180.4K
  • Earning Date
  • QNCX 03-31-2025
  • VTGN 02-13-2025
  • Dividend Yield
  • QNCX N/A
  • VTGN N/A
  • EPS Growth
  • QNCX N/A
  • VTGN N/A
  • EPS
  • QNCX N/A
  • VTGN N/A
  • Revenue
  • QNCX N/A
  • VTGN $698,000.00
  • Revenue This Year
  • QNCX N/A
  • VTGN N/A
  • Revenue Next Year
  • QNCX N/A
  • VTGN N/A
  • P/E Ratio
  • QNCX N/A
  • VTGN N/A
  • Revenue Growth
  • QNCX N/A
  • VTGN N/A
  • 52 Week Low
  • QNCX $0.51
  • VTGN $2.22
  • 52 Week High
  • QNCX $2.45
  • VTGN $5.74
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 36.52
  • VTGN 56.23
  • Support Level
  • QNCX $1.38
  • VTGN $2.60
  • Resistance Level
  • QNCX $1.49
  • VTGN $3.04
  • Average True Range (ATR)
  • QNCX 0.12
  • VTGN 0.19
  • MACD
  • QNCX -0.01
  • VTGN -0.01
  • Stochastic Oscillator
  • QNCX 7.32
  • VTGN 74.00

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: